Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit

The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit

Biocon Biologics completes integration of Viatris Biosimilars’ business in North America

Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris

NTPC partners with Apollo Hospitals to introduce Tele-Emergency and Tele-ICU Services across its 9 plants locations

These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda

Caplin Steriles receives EIR from US FDA

The inspection classification was determined by the agency as Voluntary Action Indicated

Global Digital Health Summit outlines roadmap for making India a global leader in digital health implementation

Shilpa Medicare receives UK MHRA approval for mouth-dissolving strips to treat illnesses

This approval has come from the company's finished dosage form manufacturing facility

Lupin launches propranolol capsules to improve heart health in Canada

Propranolol LA is a generic equivalent of Inderal LA

Briefs: J B Chemicals & Pharmaceuticals updates and Torrent Pharmaceuticals

The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat

Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences

Eris Lifesciences enters into term loan agreement with Citi Bank

Venus Remedies launches its flagship R&D drug Elores in Oman

The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025